International – NICE and Canadian counterpart to offer joint advice service

Agencies offer parallel scientific advice. NICE and the Canadian Agency for Drugs and Technology in Health (CADTH) have joined forces to offer pharma a health technology assessment (HTA) service.

The service will offer guidance that will help pharma develop value-based evidence by providing feedback on the company’s clinical and economical evidence generation plans.

Feedback will come armed with expert opinions spanning a range of contributors including clinicians, health economists and patient representatives.

“We recognise the inherent difficulties faced by developers in designing clinical trial programmes that meet the precise requirements of multiple international markets,” said Jeanette Kusel (pictured below), Director of NICE Scientific Advice…